HealthDay – THURSDAY, July 2 (HealthDay News) — Multaq (dronedarone) tablets
have been approved by the U.S. Food and Drug Administration to promote a
normal heart rhythm in people with atrial fibrillation or atrial flutter.
These conditions cause the heart to beat too quickly and can prevent it
from pumping blood correctly.

More: continued here